Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Pfizer, BioNTech to Supply Canada With Covid Vaccine Candidate

Aug. 5, 2020, 12:08 PM

Pfizer and BioNTech have agreed to supply the Canadian government with their BNT162 mRNA-Based vaccine candidate against Covid-19.

  • Financial details of the agreement were not disclosed, but the terms were based on the timing of delivery and the volume of doses
  • Deliveries are planned for over the course of 2021
  • Pfizer and BioNTech began a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020, and to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021
  • NOTE: On ...